Showing results (21-30 of 132) with videos related to
Sort By:
Pageof 14
International Clinical Psychopharmacology|August 2, 2017
Risk of hair loss with different antidepressants: a comparative retrospective cohort studyMahyar Etminan, Mohit Sodhi, Ric M Procyshyn, et al.Therapeutic Drug Monitoring|September 12, 2024
Implementation and Evaluation Strategies for Pharmacogenetic Testing in Hospital Settings: A Scoping ReviewAngela Wu, Edward J Raack, Colin J D Ross, et al.Therapeutic Drug Monitoring|February 2, 2023
Development of a Dose-Adjusted Polygenic Risk Model for Anthracycline-Induced CardiotoxicityAngela Siemens, Shahrad Rod Rassekh, Colin J D Ross, et al.The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|February 14, 2007
Paediatric adverse drug reaction reporting: understanding and future directionsBruce C Carleton, M Anne Smith, Michaela N Gelin, et al.Expert Opinion on Drug Metabolism & Toxicology|June 9, 2020
An update on CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effectsWan-Chun Chang, Shuen-Iu Hung, Bruce C Carleton, et al.Paediatric Drugs|March 27, 2013
Cancer pharmacogenomics in children: research initiatives and progress to dateShahrad Rod Rassekh, Colin J D Ross, Bruce C Carleton, et al.Bioinformatics (Oxford, England)|June 23, 2018
HUME: large-scale detection of causal genetic factors of adverse drug reactionsMehrdad Mansouri, Bowei Yuan, Colin J D Ross, et al.Current Opinion in Pediatrics|August 16, 2020
Prevention of adverse drug effects: a pharmacogenomic approachErika N Scott, Jafar S Hasbullah, Bruce C Carleton, et al.Drug Safety|March 14, 2024
The Role of Pharmacogenomics in Rare DiseasesAlice Man, Gabriella S S Groeneweg, Colin J D Ross, et al.The Laryngoscope|August 7, 2016
Risk of sensorineural hearing loss with macrolide antibiotics: A nested case-control studyMahyar Etminan, Brian D Westerberg, Frederick K Kozak, et al.Pageof 14